Corcept Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Increased FY24 Revenue Guidance Above Estimates
Corcept Therapeutics公佈的第一季度財務業績好於預期,且24財年收入預期高於預期,股價走高
Corcept Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Increased FY24 Revenue Guidance Above Estimates
Corcept Therapeutics公佈的第一季度財務業績好於預期,且24財年收入預期高於預期,股價走高
使用瀏覽器的分享功能,分享給你的好友吧